Results for tag: "House Dust Mite Allergy"

In the field of Allergy and Immunology, the market for House Dust Mite (HDM) allergy covers a range of products and services designed to diagnose, treat, and manage allergic reactions to dust mites. Dust mites are tiny organisms commonly found in household dust, and exposure to their waste products can trigger allergic responses in sensitive individuals, manifesting as allergic rhinitis, asthma, and atopic dermatitis. The treatment options for HDM allergy include allergen avoidance strategies, medications, and allergen immunotherapy. Allergen avoidance aims to reduce the presence of dust mites through measures like using special bedding covers, maintaining low humidity, and regular cleaning. Medications typically involve antihistamines, corticosteroids, and decongestants to alleviate symptoms. Allergen immunotherapy, also known as desensitization or allergy shots, involves gradually exposing the patient to increasing amounts of the allergen in order to build tolerance over time. Research and development in the HDM allergy market focus on improving diagnostics, developing novel treatments, and understanding the immunological mechanisms underlying the allergic response to house dust mites. Technological advancements are leading to more effective and user-friendly products, aimed at enhancing the quality of life for patients with dust mite allergies. Several companies active in the HDM allergy market include ALK-Abelló, which specializes in allergy immunotherapy treatments. Merck & Co. provides a range of pharmaceuticals, including treatments for allergic rh Show Less Read more